Literature DB >> 20826802

MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.

Yanfei Xu1, Tanushri Sengupta, Lokesh Kukreja, Alex C Minella.   

Abstract

F-box and WD-40 domain protein 7 (Fbw7) provides substrate specificity for the Skp1-Cullin1-F-box protein (SCF) ubiquitin ligase complex that targets multiple oncoproteins for degradation, including cyclin E, c-Myc, c-Jun, Notch, and mammalian target of rapamycin (mTOR). Fbw7 is a bona fide tumor suppressor, and loss-of-function mutations in FBXW7 have been identified in diverse human tumors. Although much is known about targets of the Fbw7 ubiquitin ligase pathway, relatively little is known about the regulation of Fbw7 expression. We identified a panel of candidate microRNA regulators of Fbw7 expression within a study of gene expression alterations in primary erythroblasts obtained from cyclin E(T74A T393A) knock-in mice, which have markedly dysregulated cyclin E expression. We found that overexpression of miR-223, in particular, significantly reduces FBXW7 mRNA levels, increases endogenous cyclin E protein and activity levels, and increases genomic instability. We next confirmed that miR-223 targets the FBXW7 3'-untranslated region. We then found that reduced miR-223 expression in primary mouse embryonic fibroblasts leads to increased Fbw7 expression and decreased cyclin E activity. Finally, we found that miR-223 expression is responsive to acute alterations in cyclin E regulation by the Fbw7 pathway. Together, our data indicate that miR-223 regulates Fbw7 expression and provide the first evidence that activity of the SCF(Fbw7) ubiquitin ligase can be modulated directly by the microRNA pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20826802      PMCID: PMC2966058          DOI: 10.1074/jbc.M110.152306

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.

Authors:  D M Koepp; L K Schaefer; X Ye; K Keyomarsi; C Chu; J W Harper; S J Elledge
Journal:  Science       Date:  2001-08-30       Impact factor: 47.728

2.  Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication.

Authors:  P Nash; X Tang; S Orlicky; Q Chen; F B Gertler; M D Mendenhall; F Sicheri; T Pawson; M Tyers
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

3.  Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation.

Authors:  Markus Welcker; Jeffrey Singer; Keith R Loeb; Jonathan Grim; Andrew Bloecher; Mark Gurien-West; Bruce E Clurman; James M Roberts
Journal:  Mol Cell       Date:  2003-08       Impact factor: 17.970

4.  Fbxw7 acts as a critical fail-safe against premature loss of hematopoietic stem cells and development of T-ALL.

Authors:  Sahoko Matsuoka; Yuichi Oike; Ichiro Onoyama; Atsushi Iwama; Fumio Arai; Keiyo Takubo; Yoichi Mashimo; Hideyuki Oguro; Eriko Nitta; Keisuke Ito; Kana Miyamoto; Hiroki Yoshiwara; Kentaro Hosokawa; Yuka Nakamura; Yumiko Gomei; Hiroko Iwasaki; Yasuhide Hayashi; Yumi Matsuzaki; Keiko Nakayama; Yasuo Ikeda; Akira Hata; Shigeru Chiba; Keiichi I Nakayama; Toshio Suda
Journal:  Genes Dev       Date:  2008-03-26       Impact factor: 11.361

5.  p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation.

Authors:  Alex C Minella; Jherek Swanger; Eileen Bryant; Markus Welcker; Harry Hwang; Bruce E Clurman
Journal:  Curr Biol       Date:  2002-10-29       Impact factor: 10.834

6.  The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog.

Authors:  C Oberg; J Li; A Pauley; E Wolf; M Gurney; U Lendahl
Journal:  J Biol Chem       Date:  2001-07-18       Impact factor: 5.157

7.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

8.  Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer.

Authors:  Susanna Ekholm-Reed; Charles H Spruck; Olle Sangfelt; Frank van Drogen; Elisabeth Mueller-Holzner; Martin Widschwendter; Anders Zetterberg; Steven I Reed; Susanna Ekholm Reed
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53.

Authors:  Takashi Kimura; Mitsukazu Gotoh; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Cancer Sci       Date:  2003-05       Impact factor: 6.716

10.  Prediction of mammalian microRNA targets.

Authors:  Benjamin P Lewis; I-hung Shih; Matthew W Jones-Rhoades; David P Bartel; Christopher B Burge
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

View more
  50 in total

Review 1.  Dysregulation of ubiquitin ligases in cancer.

Authors:  Jianfei Qi; Ze'ev A Ronai
Journal:  Drug Resist Updat       Date:  2015-09-28       Impact factor: 18.500

Review 2.  The two faces of FBW7 in cancer drug resistance.

Authors:  Zhiwei Wang; Hidefumi Fukushima; Daming Gao; Hiroyuki Inuzuka; Lixin Wan; Alan W Lau; Pengda Liu; Wenyi Wei
Journal:  Bioessays       Date:  2011-08-30       Impact factor: 4.345

3.  Chromosome instability underlies hematopoietic stem cell dysfunction and lymphoid neoplasia associated with impaired Fbw7-mediated cyclin E regulation.

Authors:  Ka Tat Siu; Yanfei Xu; Kelsey L Swartz; Mitra Bhattacharyya; Sandeep Gurbuxani; Youjia Hua; Alex C Minella
Journal:  Mol Cell Biol       Date:  2014-06-23       Impact factor: 4.272

4.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

5.  Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells.

Authors:  Hideyuki Shimizu; Shoichiro Takeishi; Hirokazu Nakatsumi; Keiichi I Nakayama
Journal:  JCI Insight       Date:  2019-02-21

6.  Oncogenic mutations in the FBXW7 gene of adult T-cell leukemia patients.

Authors:  Chien-Hung Yeh; Marcia Bellon; Joanna Pancewicz-Wojtkiewicz; Christophe Nicot
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

7.  An aberrant microRNA signature in childhood T-cell lymphoblastic lymphoma affecting CDKN1B expression, NOTCH1 and growth factor signaling pathways.

Authors:  L Mussolin; A B Holmes; C Romualdi; G Sales; E S G D'Amore; M Ghisi; M Pillon; A Rosolen; K Basso
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 11.528

Review 8.  MicroRNA regulation of F-box proteins and its role in cancer.

Authors:  Zhao-Hui Wu; Lawrence M Pfeffer
Journal:  Semin Cancer Biol       Date:  2015-10-01       Impact factor: 15.707

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

10.  Differential regulation of FBXW7 isoforms by various stress stimuli.

Authors:  Ronit Vogt Sionov; Efrat Netzer; Eitan Shaulian
Journal:  Cell Cycle       Date:  2013-09-24       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.